Bengaluru-based SwishX, described as the world's first agentic AI platform purpose-built for pharmaceutical and medtech companies, has been selected for the Anthropic and AWS Agentic AI Accelerator 2026, an India-first initiative supporting early-stage startups. The accelerator brings together a highly selective cohort of 40 early-stage startups building next-generation agentic AI applications capable of autonomously executing complex workflows. The program officially begins on June 26, 2026 in Bengaluru. It provides participating startups with technical mentorship, engineering and product guidance, access to Anthropic's frontier AI models and AWS cloud infrastructure, cloud credits, and opportunities to collaborate with AI researchers, product leaders, enterprise customers, and experts from Anthropic and Amazon Web Services. SwishX addresses challenges in the pharmaceutical industry by building AI agents that autonomously execute complex commercial workflows, enabling companies to improve commercial efficiency and increase revenue outcomes by up to 30%. Its platform helps pharmaceutical companies identify public tenders, detect revenue leakages, analyse real-time retailer sales, measure doctor engagement, and optimize field force execution.